Galactomannan in piperacillin-tazobactam: How much and to what extent?

被引：23
|
作者：
Machetti, M
Furfaro, E
Viscoli, C
机构：
[1] Natl Inst Canc Res, Infect Dis Unit, I-16132 Genoa, Italy
[2] Adv Biotechnol Ctr, Genoa, Italy
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 09期
关键词：
D O I：
10.1128/AAC.49.9.3984-3985.2005
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：3984 / 3985
页数：2
相关论文
共 50 条
  • [21] Reactivity of Platelia™ Aspergillus galactomannan (GM) with piperacillin-tazobactam:: Clinical implications based on achievable serum concentrations
    Singh, N
    Obman, A
    Husain, S
    Mietzner, S
    Stout, JE
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 338 - 338
  • [22] Cystic Fibrosis and Piperacillin-tazobactam: Adverse Reactions
    Diab Caceres, Layla
    Celeste Marcos, Maria
    Giron Moreno, Rosa Maria
    ARCHIVOS DE BRONCONEUMOLOGIA, 2015, 51 (12): : 664 - 665
  • [23] Reactivity of Platelia Aspergillus galactomannan antigen with piperacillin-tazobactam:: Clinical implications based on achievable concentrations in serum
    Singh, N
    Obman, A
    Husain, S
    Aspinall, S
    Mietzner, S
    Stout, JE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) : 1989 - 1992
  • [24] Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy
    Yang, Ziyi
    Mei, Jiawei
    Gong, Wei
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (11): : 1098 - 1098
  • [25] Reevaluating Piperacillin-Tazobactam Mortality-Reply
    Chanderraj, Rishi
    Dickson, Robert P.
    Sjoding, Michael W.
    JAMA INTERNAL MEDICINE, 2024, 184 (10) : 1269 - 1269
  • [26] Piperacillin-Tazobactam Penetration into Human Pancreatic Juice
    Minelli, Elisa Bertazzoni
    Benini, Anna
    Franco, Luigina
    Bassi, Claudio
    Pederzoli, Paolo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (11) : 4149 - 4152
  • [27] Fixed Drug Eruption Caused by Piperacillin-Tazobactam
    Santosa, A.
    Teo, B. W.
    Shek, L. P-C
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2013, 23 (02) : 132 - 133
  • [28] A CASE REPORT ON PIPERACILLIN-TAZOBACTAM INDUCED TRANSAMINITIS
    Joseph, Aida Mary
    Mathew, Elza
    Shaji, Jeethu K.
    Prakash, Aleena
    Menaka, K.
    Sivakumar, T.
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (10): : 9761 - 9763
  • [29] EFFECT OF PIPERACILLIN-TAZOBACTAM THERAPY ON INTESTINAL MICROFLORA
    NORD, CE
    BRISMAR, B
    KASHOLMTENGVE, B
    TUNEVALL, G
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1992, 24 (02) : 209 - 213
  • [30] PIPERACILLIN-TAZOBACTAM PHARMACOKINETICS IN PATIENTS WITH INTRAABDOMINAL INFECTIONS
    JHEE, SS
    KERN, JW
    BURM, JP
    YELLIN, AE
    GILL, MA
    PHARMACOTHERAPY, 1995, 15 (04): : 472 - 478
12345